Importance of taking into consideration new and traditional treatment options for CLL patients
Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus
The challenges associated with managing multiple myeloma patients on immunotherapy
Ignacio Melero Bermejo
The 2016 International Workshop of the German CLL Study Group (GCLLSG)
Can ibrutinib be used as a first-line treatment in CLL?